Pharmacielo schedules AGM, plans debt settlement

Executive Summary

• Pharmacielo Ltd. announced its intention to issue 12,153,937 common shares to settle $972,317.12 in accrued semi-annual interest payments on its 11% secured debentures.
• The issuance is subject to approval by the TSX Venture Exchange and sets the record date for the upcoming Annual General Meeting (AGM) for April 2, 2026.
• The effective price per share is eight cents, calculated based on the terms of the debentures and TSX Venture Exchange Policy 4.3.

Key Details

• Share Issuance: 12,153,937 common shares of Pharmacielo Ltd.
• Purpose: Satisfaction of aggregate accrued semi-annual interest payments totaling $972,317.12.
• Debenture Terms: 11% secured debentures.
• Effective Price: $0.08 per interest share.
• Regulatory Approval: Subject to approval by the TSX Venture Exchange.
• Compliance: Calculation determined in accordance with debenture terms and TSX Venture Exchange Policy 4.3, Section 3.3.
• Hold Period: Shares are subject to any applicable statutory hold period under Canadian securities laws.
• AGM Details:
  • Date: April 2, 2026.
  • Record Date: February 23, 2026.
  • Materials: To be filed on SEDAR+.

Notable Quotes

• No direct quotes from management were included in the provided text.